AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03880123 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixazomib
Description: Ixazomib will be taken orally on Days 1, 8, and 15 of each cycle at the same dose level: 4 mg.~The ixazomib product is provided in strengths of 4.0, 3.0, and 2.3 mg capsules as the active boronic acid. Ixazomib should be taken on an empty stomach (no food or drink) at least 1 hour before or at least 2 hours after food.
Study NCT04331210 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac Sodium
Description: Group 1 will take oral diclofenac sodium and group 2 will take Rectal diclofenac sodium as an analgesic
Study NCT02458352 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Ultra low dose non-contrast enhanced CT
Description: Non-contrast enhanced CT for CACS and AC using a novel protocol for ultra low dose radiation dose exposure
Study NCT02458352 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Standard dose non-contrast enhanced CT
Description: Clinically indicated non-contrast enhanced CT for CACS and AC according to routine protocol
Study NCT01381731 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: diquafosol tetrasodium ophthalmic solution 2%
Description: opthalmic solution 2 drops in each eye QID
Study NCT01381731 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: opthalmic solution 2 drops in each eye QID
Study NCT04051489 — intervention group
Intervention type: OTHER
Intervention: Mobile health App - Test
Description: Beta Testing 1: The Beta test 1 will be performed with participants inside the Research Center. The purpose of this phase is to increase usability, acceptability and reliability of the mHealth App in participants with knee osteoarthritis (KOA).~Beta Testing 2: The Beta test 2 will be performed with patients outside the Research Center, at their houses. The purpose is to focus on the mHealth App remote usability, acceptability, and data collection.
Study NCT01856179 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Echium oil
Description: Oil of Echium platagineum (natural plant oil) ca. 15-18 g/d (Croda)
Study NCT01985204 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Iodine tablet
Description: Iodine tablets containing 200 ug iodine as potassium iodate
Study NCT01985204 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tablet
Description: Placebo tablet without iodine
Study NCT00050570 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-based intervention to reduce eating disorder risk factors
Study NCT03508245 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Wearable short wavelength light therapy
Description: Wearable short wavelength (i.e., blue-green) light-emitting glasses worn for two weeks
Study NCT02931955 — intervention group
Intervention type: OTHER
Intervention: Blood draw, stool collection.
Description: Blood will be drawn by certified personnel according to local regulations. Stool will be collected by the patients after instructions on how to use a stool collection kit.
Study NCT02388165 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Vaccine excipients reconstituted in 0.5mL water for injections. Administered via IM injection given 10 to 60 days prior to surgery
Study NCT02727595 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CyclaPlex Implant
Description: Button and suture type implant that will be implanted between the first and second metatarsal
Study NCT01720004 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Repeated hands-and-knees positioning during labour
Description: Details are in the Arm Description.
Study NCT02236234 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HPV vaccine
Description: HPV vaccine
Study NCT02676700 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic floor muscle training and Kaatsu
Description: The intervention includes three outpatient visits (weeks 0, 6 and 12) and between visits the participants perform PFMT and Kaatsu training as home training
Study NCT02676700 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic floor muscle training
Description: The intervention includes three outpatient visits (weeks 0, 6 and 12) and between visits the participants perform PFMT as home training
Study NCT03970876 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ATGC-100
Description: Clostridium Botulinum Type A
Study NCT03970876 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Botox®
Description: Clostridium Botulinum Type A
Study NCT00705497 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency Tumor Ablation
Description: Radiofrequency tumor ablation (RFA) is an imaging guided percutaneous or intra-operative procedure that uses a probe on the end of a sharp needle that is inserted directly into the tumor. The tumor is ablated by heating the probe (using electrical current alternating at radio frequency) which raises the temperature of the tumor potentially causing irreversible cell death.
Study NCT04299750 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tooth extraction and Alveolar ridge preservation
Description: Tooth extraction and alveolar ridge preservation with deproteinized bovine bone mineral and a collagen matrix seal
Study NCT04299750 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tooth extraction
Description: Tooth extraction and socket natural healing
Study NCT01321658 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Geriatric intervention
Description: A comprehensive geriatric assessment (CGA), focusing on co-morbidity, medication, cognitive status, depression, nutritional status and physical status is performed. The intervention is individualized according to the results of the CGA.
Study NCT01855204 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Computed tomographic urography
Description: Computed tomographic (CT) urography was done with the protocols of low voltage and low iodine concentration.
Study NCT01855204 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Computed tomographic urography
Description: Computed tomographic (CT) urography was done with the protocols of low voltage and low iodine concentration.
Study NCT03105869 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: fluorocholine PET/CT
Description: standard diagnostic PET/CT procedure
Study NCT01529827 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fludarabine phosphate
Description: Given IV
Study NCT03972735 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Psychiatric interview
Description: PANSS, MADRS, PSP, YMRS
Study NCT01529827 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: melphalan
Description: Given IV
Study NCT01529827 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: total-body irradiation
Description: Undergo TBI
Study NCT01529827 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tacrolimus
Description: Given IV or PO
Study NCT01529827 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mycophenolate mofetil
Description: Given IV or PO
Study NCT03972735 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical, diagnostic and functional evaluation
Description: ISMI, STORI, SERS, S-QOL, WEWMBS, BIRCHWOOD, MARS
Study NCT01529827 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methotrexate
Description: Given IV
Study NCT03972735 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Clinical, diagnostic and functional evaluation
Description: ISMI, STORI, SERS, S-QOL, WEWMBS, BIRCHWOOD, MARS
Study NCT03972735 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: neuropsychological assessment
Description: WAIS IV, BEM 144, TMT A, TMT B, D2-R, V-LIS
Study NCT03972735 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: neuropsychological assessment
Description: WAIS IV, BEM 144, TMT A, TMT B, D2-R, V-LIS
Study NCT03972735 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NECT PROGRAM
Description: Narrative Development and Cognitive Therapy (NECT) is a 12 session group-based manualized intervention combining psychoeducation, cognitive restructuring and narrative enhancement. The 2h sessions are conducted by two trained facilitators.
Study NCT03972735 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: NECT PROGRAM
Description: Narrative Development and Cognitive Therapy (NECT) is a 12 session group-based manualized intervention combining psychoeducation, cognitive restructuring and narrative enhancement. The 2h sessions are conducted by two trained facilitators.
Study NCT02505308 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose-Potentiated Arginine-Induced Insulin Secretion
Description: Intravenous catheters are inserted into antecubital veins in both arms. One arm is used for infusion of glucose/amino acid (Arginine). The other arm is used for intermittent sampling.
Study NCT01529827 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT01438996 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NVGH Vi-CRM197
Description: Vi-CRM197 glycoconjugated vaccine
Study NCT01804348 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AL-SENSE 1-Step
Description: a single AL-SENSE 1-Step to use up to 12 hours or until they notice any wetness.
Study NCT01529827 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: allogeneic hematopoietic stem cell transplantation
Description: Undergo allogeneic PBSCT
Study NCT01529827 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: peripheral blood stem cell transplantation
Description: Undergo PBSCT
Study NCT06419790 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EIT electrode belt, spirometry
Description: Placing electrode belt for EIT monitoring and measuring tidal volume with spirometer
Study NCT03149497 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: anterior approach only in cervical spine trauma
Description: evaluation of efficacy of single approach
Study NCT02961400 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PUSH text messages
Description: The intervention is designed to remind participants of treatment components.
Study NCT02961400 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PULL text messages
Description: The intervention is designed to remind participants to recall treatment components.
Study NCT02961400 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: TranS-C
Description: The Transdiagnostic Sleep and Circadian Intervention (TranS-C) integrates evidence-based treatments derived from basic research on the circadian system.
Study NCT02961400 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TranS-C
Description: The Transdiagnostic Sleep and Circadian Intervention (TranS-C) integrates evidence-based treatments derived from basic research on the circadian system.
Study NCT02961400 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: PE
Description: Psychoeducation on the inter-associations between sleep, diet, exercise and stress.
Study NCT02961400 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PE
Description: Psychoeducation on the inter-associations between sleep, diet, exercise and stress.
Study NCT03381352 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Chemo-radiotherapy with IMRT technique
Description: IMRT radiation technique; 50.4-54Gy/25F
Study NCT03381352 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine 825mg/m2 PO BID
Study NCT03381352 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitomycin C
Description: Mitomycin C 10mg/m2 D1,29 iv
Study NCT00675311 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: DM-Standard
Description: Device/t+ Medical Diabetes Management System
Study NCT00675311 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Disease Management Plus
Description: Plus is one of the randomized arms of the study. Patients assigned to this arm receive support from Disease Management nurses and technology.
Study NCT03934489 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PERSIST
Description: 12-week group, adapted from Dialectical Behavior Therapy, that focuses on emotion regulation skills training and practice.
Study NCT03934489 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Facilitated Peer Support
Description: 12-week group, adapted from community-based peer support groups, that focuses on participant-generated topics and facilitated discussion.
Study NCT00766181 — intervention group
Intervention type: BEHAVIORAL
Intervention: Zingo TM (lidocaine hydrochloride monohydrate) powder intradermal injection system
Description: 0.5 mg lidocaine hydrochloride
Study NCT01800162 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate
Description: Two Dose Protocol: The patient will receive the first dose of MTX 50mg/m2 on treatment day 0. She will receive a second dose of MTX 50mg/m2 on treatment day 4 and a serum hCG level will be drawn. Subsequent doses of MTX will be administered based on hCG levels.
Study NCT01800162 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Uterine Evacuation
Description: Uterine evacuation or dilation and curettage. At the clinician's discretion, this can be performed using local anesthesia, sedation or general anesthesia and can use a manual or electrical evacuation.
Study NCT01800162 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Expectant Management
Description: Pregnancy will be expectantly managed using serum hcg monitoring.
Study NCT00939055 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: StomaphyX
Description: Transoral incisionless fastening device that allows for GI tissue approximation and creation of full-thickness (serosa-to-serosa) plications.
Study NCT00939055 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham procedure
Description: False procedure
Study NCT02672644 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Emervel Classic
Description: Subjects requiring bilateral correction of NLFs and meeting eligibility criteria will be enrolled and treated with Emervel Classic (moderate NLFs; WSRS = 3/3)
Study NCT02672644 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Emervel Deep
Description: Subjects requiring bilateral correction of NLFs and meeting eligibility criteria will be enrolled and treated with Emervel Deep (severe NLFs; WSRS = 4/4).
Study NCT02374359 — intervention group
Intervention type: OTHER
Intervention: follow-up
Study NCT02371694 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Test drink
Description: The intervention is a drink taken 4 hours after the evening meal insulin injection, or 10PM, whichever is later. All drinks are 116-120g in weight and similar volume.~All drinks are served in a double blind fashion, apart from the 20g carbohydrate which is visibly different from other drinks in colour, texture and flavour.
Study NCT02371694 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Test drink
Description: The intervention is a drink taken 4 hours after the evening meal insulin injection, or 10PM, whichever is later. All drinks are 116-120g in weight and similar volume.~All drinks are served in a double blind fashion, apart from the 20g carbohydrate which is visibly different from other drinks in colour, texture and flavour.
Study NCT02371694 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Test drink
Description: The intervention is a drink taken 4 hours after the evening meal insulin injection, or 10PM, whichever is later. All drinks are 116-120g in weight and similar volume.~All drinks are served in a double blind fashion, apart from the 20g carbohydrate which is visibly different from other drinks in colour, texture and flavour.
Study NCT01755390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabazitaxel (XRP6258)
Description: Pharmaceutical form: infusion solution Route of administration: Intravenous
Study NCT00444834 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carvedilol
Description: 50 mg
Study NCT00444834 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carvedilol
Description: 50 mg
Study NCT00613340 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cervical medial branch blocks
Description: Cervical medial branch blocks done with 0.25 ml of local anesthetic and contrast
Study NCT00613340 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cervical medial branch blocks
Description: Cervical medial branch blocks with 0.5 ml of local anesthetic and contrast
Study NCT01528618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine and cisplatin
Description: The GP regimen consists of gemcitabine at a dose of 1,000 mg/m2 by intravenous (i.v.) infusion over 30 min on day 1 and day 8, and cisplatin 80 mg/m2 by i.v. infusion for 4 h on day 1 only
Study NCT01528618 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-Fluorouracil and cisplatin
Description: The FP regimen consists of 5-Fluorouracil 1,000 mg/m2/day which was administered as a continuous intravenous infusion for 96 hours after completion of the cisplatin on days 1( 80 mg/m2 i.v. infusion for 4 h)
Study NCT04146129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CDX-0159
Description: Single dose of one of four dosages of CDX-0159
Study NCT04146129 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Single infusion of normal saline
Study NCT04394013 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Description: Gentle body stretching with the incorporation of breathing technique
Study NCT04394013 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Non-Mindfulness intervention
Description: Gentle body stretching without the incorporation of breathing technique
Study NCT03826316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nalbuphine
Description: Pharmacokinetic study under fasting conditions
Study NCT03518775 — intervention group
Intervention type: DEVICE
Intervention: Biometry
Description: Measurement of Cornea
Study NCT02000544 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Modular Cardiopulmonary Bypass Circuit
Description: Open heart surgery with a novel hybrid modular extracorporeal circulation circuit which is a closed cardiopulmonary bypass circuit with enhanced safety as it can be instantly converted to an open circuit.
Study NCT01428414 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trastuzumab
Description: 2 mg/kg, iv, d1,8,15(loading dose 4mg/kg wk1), qw
Study NCT01428414 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: 75mg/m2, iv d1, 8,15. qw; 4-6 cycles
Study NCT01428414 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epirubicin
Description: 75mg/m2, iv d1, q3w, 4-6 cycles
Study NCT01428414 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: AUC 2, qw, iv d1, 8,15. 4-6 cycles
Study NCT01996228 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stem Cell Educator
Study NCT01965028 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial random noise stimulation (tRNS)
Description: High frequency tRNS (Neuroconn, Eldith DC-Stimulator Plus): 100-650Hz, 2mA, 20min, 10s ramp time, left and right auditory cortex, 5x7cm electrode with the inferior middle part over T3/T4 Arms: tRNS
Study NCT03377829 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PLA
Description: During the PLA, the patient is in supine position with head extended: the physician, ultrasound assistant and trained nurse work within the sterile field. Under constant ultrasound image guidance and after local anesthesia by means of 2% xylocaine infiltration, thin needles (21G) are positioned in the thyroid lesion, within safety distance from the surrounding anatomical structures. A plane-cut tip fiber optics is inserted into the PTMC through the needle. The laser at 1064 nm wavelength is turned on for 10 minutes until the pre-established energy dose is attained. There is usually no pain or very limited pain.
Study NCT03377829 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thyroid Surgery
Description: Patients are routinely disinfected and spread the drapes after general anesthesia. Neck skin, fat, placenta muscle are incised successively. The flap is separated to the upper edge of thyroid cartilage, neck white line is incised and anterior muscle group is separated. Then both sides thyroid lobes are exposed. Cut off the isthmus, ligature the thyroid artery, cut off the upper pole. Ligature and cut off the ipsilateral thyroid vein. Reveal and protect the ipsilateral recurrent laryngeal nerve and the parathyroid gland during the entire process. Finally patient is performed total thyroidectomy or subtotal thyroidectomy.